This grant, offered by the National Institutes of Health (NIH), supports clinical research into psychedelic treatments for Alcohol and Substance Use Disorders (ASUD). The initiative focuses on refining and optimizing administration paradigms, exploring novel clinical trial designs, and assessing psychotherapy’s role in these treatments. Successful applications will study the range of clinical outcomes and downstream functional effects resulting from psychedelic interventions. This opportunity addresses the urgent need to advance therapeutic applications in the ASUD field by thoroughly evaluating the beneficial clinical and functional impacts of psychedelic treatments, thereby building a robust evidence base for future therapies.
Opportunity ID: 350819
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-25-058 |
| Funding Opportunity Title: | Psychedelics Treatment Research in Substance Use Disorder (UG3/UH3 Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 01, 2023 |
| Last Updated Date: | Nov 01, 2023 |
| Original Closing Date for Applications: | Feb 28, 2024 |
| Current Closing Date for Applications: | Feb 28, 2024 |
| Archive Date: | Apr 04, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $2,000,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts For profit organizations other than small businesses County governments Public and State controlled institutions of higher education Small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Psychedelic treatments are currently in clinical development for a range of mental disorders. Therapeutic areas undergoing active clinical research include alcohol and substance use disorders (ASUD). The exploration of the beneficial clinical and functional outcomes require our urgent attention to the refinement and optimization of the psychedelic treatment administration paradigms, and an exploration of novel clinical trial designs, which are of high nascent interest for the ASUD field in general. This Concept supports clinical studies applications to study psychedelic treatment administration paradigms, assess the role of psychotherapy in its administration, and describe and assess the range of clinical outcomes, including downstream functional effects, that are evidenced as the result of this treatment |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-058.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350819 Full Announcement-RFA-DA-25-058 -> RFA-DA-25-058-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283667 | Jan 28, 2024 | Feb 28, 2024 | View |
Package 1
Mandatory forms
350819 RR_SF424_5_0-5.0.pdf
350819 PHS398_CoverPageSupplement_5_0-5.0.pdf
350819 RR_OtherProjectInfo_1_4-1.4.pdf
350819 PerformanceSite_4_0-4.0.pdf
350819 RR_KeyPersonExpanded_4_0-4.0.pdf
350819 RR_Budget10_3_0-3.0.pdf
350819 PHS398_ResearchPlan_5_0-5.0.pdf
350819 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350819 RR_SubawardBudget10_30_3_0-3.0.pdf
350819 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
